期刊文献+

布洛芬缓释胶囊治疗腰椎融合术后疼痛疗效分析

Efficay of Ibuprofen for postoperative pain after lumbar spinal fusion
下载PDF
导出
摘要 目的评价布洛芬缓释胶囊(芬必得)对腰椎融合手术后急性疼痛的疗效。方法将60例准备接受腰椎融合手术的患者按照随机双盲方法分为2组:布洛芬加阿片类药物组(芬必得组)和塞来昔布加阿片类药物组(塞来昔布组)。塞来昔布组患者术前8 h口服塞来昔布片200 mg,术后1~5 d每12 h口服200 mg;芬必得组术前8 h服用维生素C 100 mg,术后6 h服用芬必得900 mg,之后1~5 d每12 h服用900 mg。两组均在术后第1天采用PCA装置给予芬太尼镇痛以及术后2~5 d改为口服奇曼丁镇痛。术后两组病人均应用奥美拉唑预防应激性溃疡。于术后4、8、12、16、24、36、72、96 h行VAS评分评估手术后镇痛效果,并记录PCA药物用量。结果在术后8 h以内及手术后96 h两组患者手术切口疼痛的VAS评分结果无统计学意义(P>0.05),而术后8~72 h,芬必得组VAS评分较塞来昔布组更低(P<0.05)。术后1~8 h芬太尼用量两组没有统计学差异(P>0.05),术后12~24 h芬必得组芬太尼用量较小(P<0.05)。术后1 d两组患者口服奇曼丁用量无统计学差异(P>0.05),术后2~5 d芬必得组奇曼丁用量更小(P<0.05)。术后1~5 d两组恶心、呕吐次数无统计学差异(P>0.05)。结论腰椎融合手术后短期应用布洛芬缓释胶囊辅助镇痛,镇痛疗效优于塞来昔布,可减少阿片类药物用量,胃肠道副反应未见增加。 Obective To evaluate the efficacy of Ibuprofen(Fenbid) in the treatment of postoperative pain after lumbar spinal fusion.Methods Totally 60 patients preparing to receive lumbar spinal fusion were divided into Ibuprofen plus Opioids group(Fenbid group) and Celecoxib plus Opioids group(Celecoxib group) according to double blind trial.Patients in Celecoxib group were received 200 mg Celecoxib before operation and every 12 hours in the following 1~5 days.Patients in Ibuprofen group were given 100 mg vitamin C before operation and 900 mg Ibuprofen 6 hours after operation and every 12 hours in following 1~5 days.All patients were received Fentanyl through patient-controlled analgesia(PCA) pump at the first day after operation and took Tramadol orally in the following 2~5 days to relieve pain.Omeprazol was applied to prevent stress ulcer.Analgesic effect was evaluated using visual analog scores(VAS) at 4、8、12、16、24、36、72、96 hours after operation and doses of PCA drug were recorded.Results There was no statistical difference in VAS scores between two groups within 8 hours and at 96 hours post surgery(P0.05),however the VAS scores in Fenbid group were lower than those in Celecoxib group significantly at 8~72 hours post surgery(P0.05).There was no statistical difference in the dosage of Fentanyl between two groups within 8 hours post surgery(P0.05),however,the dosage was lower in Fenbid group at 12~14h post surgery.No statistic difference in oral dosage of Tramadol was found between two groups at the first day post surgery(P0.05),however,the dosage was lower in Fenbid group than that in Celecoxib group at 2~5 days post surgery(P0.05).No statistic difference in the frequency of nausea and vomiting at 1~5 days post surgery was found(P0.05).Conclusion Short-term oral administration of Ibuprofen after lumbar spinal fusion can get better analgesic effect than Celecoxib and can reduce the opioids requirements without increasing the incidences of gastrointestinal reactions.
出处 《局解手术学杂志》 2011年第5期540-542,共3页 Journal of Regional Anatomy and Operative Surgery
关键词 腰椎融合 术后疼痛 布洛芬 非甾体抗炎药 lumbar spinal fusion postoperative pain Ibuprofen non-steroidal anti-inflammatory drug
  • 相关文献

参考文献11

  • 1Crofford LJ,Wilder RL,Ristimaki AP,et al.Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues.Effects of interleukin-1 beta,phorbol ester,and corticosteroids[J].J Clin Invest,1994,93(3):1095-1101.
  • 2Crofford LJ,Lipsky PE,Brooks P,et al.Basic biology and clinical application of specific cyclooxygenase-2 inhibitors[J].Arthritis Rheum,2000,43(1):4-13.
  • 3Jackson LM,Hawkey CJ.COX-2 selective nonsteroidal anti-inflammatory drugs:do they really offer any advantages?[J].Drugs,2000,59(6):1207-1216.
  • 4张立,欧国荣,孙宇,潘胜发.围手术期使用塞来昔布对腰椎手术患者的镇痛作用[J].中国脊柱脊髓杂志,2007,17(8):619-622. 被引量:24
  • 5施桂英.选择性环氧化酶-2抑制剂的十年浮沉[J].中华风湿病学杂志,2010,14(5):289-292. 被引量:4
  • 6朱毓,吴美华.非甾体类抗炎药与心血管疾病的研究进展[J].中国临床药理学与治疗学,2008,13(3):350-354. 被引量:8
  • 7Reuben SS,Ekman EF.The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion[J].J Bone Joint Surg Am,2005,87(3):536-542.
  • 8Juni P,Rutjes AW,Dieppe PA.Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs[J].BMJ,2002,324(7349):1287-1288.
  • 9Clark E,Plint AC,Correll R,et al.A randomized,controlled trial of acetaminophen,ibuprofen,and codeine for acute pain relief in children with musculoskeletal trauma[J].Pediatrics,2007,119(3):460-467.
  • 10Andersohn F,Suissa S,Garbe E.Use of first-and second-generation cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction[J].Circulation,2006,113(16):1950-1957.

二级参考文献55

  • 1张立贤,王家双,彭亮,杨庆耿,王爱群,陈剑龄,舒慧芳.罗非昔布超前镇痛在无痛人流术中的应用[J].中国疼痛医学杂志,2005,11(1):22-24. 被引量:7
  • 2李芹,王睿,陈騉.高选择性COX-2抑制剂罗非昔布撤市分析[J].中国临床药理学与治疗学,2005,10(3):259-264. 被引量:3
  • 3刘慧丽,黄宇光.阿片类药物胃肠道不良反应的临床研究进展[J].临床麻醉学杂志,2005,21(5):352-354. 被引量:40
  • 4辜晓岚,徐建国.塞莱昔布超前镇痛在骨科手术的应用[J].临床麻醉学杂志,2006,22(1):19-21. 被引量:34
  • 5Crofford LJ,Lipsky PE,Brooks P,et al.Basic biology and clinical application of specific cyclooxygenas-2 inhibitors.Arthritis Rheum,2000,43:4-13.
  • 6AMERICAN COLLEGE of RHEUMATOLOHY AD HOC GROUP on USE of SELECTIVE and NONSELECTIVE NONSTEROIDAL.Antiinflammatory drugs.Recommendations for use of selective and nonselective nonster-oidal anti-inflammatory drugs:an American College of Rheumatology White Paper.Arthritis Rheum,2008,59:1058-1073.
  • 7Stichtenoth DO.Frolich J.The second generation of COX-2 inhibitors:what advantages do the newest offer.Drugs,2003.63:33-45.
  • 8Juni P,Rutjes AW,Dieppe PA.Are selective COX-2 inhibitors superior to traditional nonsteroidal anti-inflammatory drugs.BMJ,2002,324:1287-1288.
  • 9Bresalier RS,Sandler RS,Quan H,et al.Cardivascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.N Engl J Med,2005,352:1092-1102.
  • 10Solomon SD,McMurray JJV,Pfeffer MA,et al.Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.N Engl J Med,2005,352:1071-1080.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部